The president and executive medical director of Washington Permanente Medical Group stressed distribution simulations and constant communications as key factors to efficient vaccine rollout.
Peter Barkett, MD, an internist with Washington Permanente Medical Group, examines the history of vaccines and how they are powerful tools to promote public health.
Paul Minardi, MD, president and executive medical director of Washington Permanente Medical Group, surveys the history of pandemics and finds that infectious disease outbreaks have driven transformation and innovation in public health.
David Grossman, MD, of Washington Permanente Medical Group, and Eric Larson, MD, of Kaiser Permanente Washington Health Research Institute, published a peer-reviewed viewpoint in JAMA about the potentially powerful implications of population genomics for the future of health care.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
In a recent article by The Wall Street Journal, Eric Larson, MD, a physician with Washington Permanente Medical Group and senior investigator for the Kaiser Permanente Washington Health Research Institute, is quoted about dementia prevention research published in a report commissioned by the Lancet medical journal.
As part of a growing partnership, Permanente physicians are working to provide world-class care for Special Olympics athletes across multiple specialties.
To provide the best experience, we use cookies to store and/or access device information, and to process data such as browsing behavior or unique IDs. Please click Accept to give us permission to personalize content and enable analytics. Note that opting out may adversely affect your access to certain features and functions, such as video and audio playback.
Functional
Always active
These cookies are essential for the site to function. The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.These cookies allow us to gather nonidentifiable information such as number of site visits. The technical storage or access is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
These cookies can be used to provide you with relevant advertisements, although we do not typically target users with ads. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.